The Legal 500

Twitter Logo Youtube Circle Icon LinkedIn Icon
KLAUSSTRASSE 33, 8024 ZURICH, SWITZERLAND
Tel:
Work +41 44 421 45 45
Fax:
Fax +41 44 421 45 00
Email:
Web:
www.thouvenin.com

Arlette Pfister

Tel:
Work +41 44 421 45 45
Email:
Thouvenin Rechtsanwälte

Work Department

Corporate & Commercial, Mergers & Acquisitions, Venture Capital, Employment & Migration

Position

Arlette Pfister is a partner at Thouvenin Rechtsanwälte. She mainly practices in the field of corporate law, employment law, commercial law and contract law. Arlette focuses particularly on the advice of international groups regarding restructuring projects, the advice of companies and international groups with regard to complex and general corporate and corporate group legal issues as well as the advice and assistance with regard to daily corporate housekeeping. Arlette Pfister also advises companies and private individuals regarding the negotiation, structuring and drafting of commercial contracts and immigration issues and work permits. Furthermore, Arlette Pfister also has experience in the fields of alternative dispute resolutions, life science and health care law and data protection matters.

Career

Since  07/2016              Partner, Thouvenin Rechtsanwälte KLG, Zurich

2001 - 06/2016              Associate, Thouvenin Rechtsanwälte KLG, Zurich

1999 - 2001                   Associate, Hayman & Baldi, Zurich

1997 - 1998                   Junior Associate, Meyer Lustenberger & Partner, Zurich

1996 - 1997                   Court clerk, District Court of Hinwil

Languages

German, English, French

Member

Swiss and Zurich Bar Association

Education

2005                            University of Westminster, London, Master of Laws in International &
                                     Commercial Dispute Resolution (LL.M.)

2003                            University of Applied Sciences and Arts Northwestern Switzerland,
                                    CAS Mediator in commercial, environmental and administrative matters

1999                            Admission to the Bar

1996                            University of Zurich, Master of Law (lic. iur.)


Switzerland

Commercial, corporate and M&A

Within: Commercial, corporate and M&A

Thouvenin Rechtsanwälte's national and international M&A clients mostly come from the manufacturing, healthcare and technology industries. Other areas of expertise include corporate advice, commercial leasing and distribution issues, as well as structuring financial investments. Microsoft, EOS Group, Hexagon and Leica Geosystems are among its clients. The team comprises of cross-border specialist Arlette PfisterMarkus Alder, who focuses on mid-sized M&A transactions, corporate and insurance specialist Martin Bürkle and commercial lawyer Michael Bösch.

[back to top]


Back to index

Legal Developments in Switzerland

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to
  • Bär & Karrer Continues to Grow Finance and Sports Practice with Two New Partners

    Bär & Karrer is pleased to announce that it further strengthens its Financing and Sports practices with new partners Lukas Roesler and Dr. Jan Kleiner, both of whom have worked with the firm previously.
  • Bär & Karrer Advises Novartis and Alcon on the Spin-off of Alcon

    Today, Novartis AG completed the spin-off of the Alcon eye care devices business, and Alcon Inc. debuted as independent publicly traded company. The Alcon shares were successfully listed on the SIX Swiss Exchange Ltd. and the New York Stock Exchange. They are also included in the Swiss Market Index (SMI), which comprises the 20 largest Swiss listed stocks.
  • Bär & Karrer Advises Primeo Energie and CSA Energie-Infrastructure Schweiz in Aquisition from Elét

    Primeo Energie, EOS Holding SA (EOS) and Électricité de France (EDF) have entered into a share purchase agreement relating to the purchase by Primeo Energie and EOS of the 25% interest held by EDF in Alpiq Holding SA. The purchase by Primeo Eergie and EOS will be financed through mandatory exchangeable loan agreements made by CSA Energie-Infrastruktur Schweiz (CSA) as lender, the biggest investment pool for Swiss energy infrastructure with 135 Swiss pension funds acting as investors. At maturity the mandatory exchangeable loan agreements will be converted into shares in Alpiq. Primeo Energie and EOS thereby pave the way for a Swiss shareholder structure of Alpiq.
  • Bär & Karrer Awarded Most Innovative Swiss Law Firm of the Year at the IFLR Europe Awards

    Bär & Karrer was awarded „Most innovative law firm of the year - Switzerland", the national award for Switzerland given in the IFLR European Awards. The most innovative law firm of the year award recognizes Bär & Karrer as the Swiss law firm with the best track record in 2018 giving advice on the most innovative cross-border deals covering all award practice areas. It is already the third prize of this kind in period of six years awarded to Bär & Karrer.
  • Bär & Karrer Advises DSV on Public Exchange Offer for Panalpina

    On 1 April 2019, DSV A/S, Hedehusene, Denmark and Panalpina Welttransport (Holding) AG, Zurich, Switzerland, have entered into an agreement on the terms and conditions of a combination by way of a public exchange offer by DSV for all publicly held registered shares of Panalpina for approximately CHF 4.6 billion. The board of directors of Panalpina has resolved to support the public exchange offer by DSV and to recommend the acceptance of DSV's public exchange offer to its shareholders.
  • Bär & Karrer Advises Lonza on the Entering into a Strategic Joint Venture with Chr. Hansen for Deve

    On 2 April 2019, Lonza, a leading pharma contract manufacturing company, and Chr. Hansen, a leading global bioscience company, announced that they have signed an agreement to establish a 50/50 joint venture to pioneer the live biotherapeutic products (LBPs) industry and position themselves as the leading contract development and manufacturing partner (CDMO) for biotech and pharma customers. The joint venture brings together best-in-class, complementary capabilities and will be the first CDMO globally to provide a full supply chain that offers manufacturing of bacteria strains for therapeutic use. The joint venture will be a 50/50 controlled legal entity that will operate from its headquarters in Basel (CH) and have production facilities in Denmark and Switzerland. A phased investment of approximately EUR 90 million will be deployed over three years to build cGMP-compliant pharma production capabilities. The joint venture will upgrade existing facilities in Hørsholm (DK) and equip new facilities in Basel (CH) to serve pre-clinical to phase II projects. Further facilities for phase III and commercial manufacturing will be developed as the pipeline matures. The joint venture is expected to be largely self-funding after the production set-up has been established.
  • Bär & Karrer Advises Computacenter in the Acquisition of PathWorks

    Computacenter Group, a leading European IT service provider listed on the London Stock Exchange, acquired PathWorks, a well-established hardware reseller in the Swiss market.
  • Bär & Karrer Advises Addtech in the Acquisition of a Majority in Omni Ray

    Addtech Group, a leading Swedish publicly listed technology trading group, acquired a majority stake in Omni Ray AG, a well-established Swiss trading company and service provider for automation solutions, mainly focused on industrial applications, infrastructure, transportation and medical industry. By this transaction, Addtech aims at strengthening its position in the European automation market.
  • Bär & Karrer Partner Paolo Bottini Wins the Client Choice Award 2019 by Lexology

    Bär & Karrer is pleased to announce that partner Paolo Bottini has been recognized by Lexology and the International Law Office (ILO) as the Client Choice Winner 2019 in the Corporate Tax category in Switzerland.
  • Bär & Karrer Advises CEVA Logistics in Connection with the Strengthening of the Strategic Partnersh

    On 11 October 2018, the board of directors of CEVA Logistics AG announced that the Danish transport and logistic company DSV submitted a non-binding letter of interest with an indicative offer price of CHF 27.75 per CEVA share and that the board of directors of CEVA came to the conclusion that the offer was not in the best interest of the company and its shareholders. This was in particular because at that point in time, CEVA was already in discussions regarding an intensified cooperation with its main shareholder CMA CGM S.A., which shall exploit the full potential of CEVA.